Reflect Scientific, Inc.
RSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,598 | $5,667 | $5,210 | $10,160 |
| - Cash | $1,014 | $1,278 | $1,382 | $1,474 |
| + Debt | $196 | $243 | $57 | $114 |
| Enterprise Value | $2,780 | $4,632 | $3,885 | $8,800 |
| Revenue | $1,877 | $1,080 | $2,041 | $2,815 |
| % Growth | 73.8% | -47.1% | -27.5% | – |
| Gross Profit | $558 | $596 | $1,219 | $1,931 |
| % Margin | 29.7% | 55.2% | 59.7% | 68.6% |
| EBITDA | $242 | -$406 | $146 | $885 |
| % Margin | 12.9% | -37.6% | 7.2% | 31.4% |
| Net Income | $169 | -$459 | $89 | $939 |
| % Margin | 9% | -42.5% | 4.4% | 33.4% |
| EPS Diluted | 0.002 | -0.005 | 0.001 | 0.011 |
| % Growth | 137% | -640% | -91% | – |
| Operating Cash Flow | – | -$104 | -$92 | $831 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$104 | -$92 | $831 |